John W. Brooker & Co., CPAs - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 284 filers reported holding NEKTAR THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
John W. Brooker & Co., CPAs ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$0400.0%0.00%
Q2 2022$0400.0%0.00%
Q1 2022$0
-100.0%
400.0%0.00%
-100.0%
Q4 2021$1,0000.0%400.0%0.00%0.0%
Q3 2021$1,0000.0%40
-7.0%
0.00%0.0%
Q2 2021$1,000
-50.0%
43
+7.5%
0.00%0.0%
Q1 2021$2,000
+100.0%
400.0%0.00%0.0%
Q4 2020$1,0000.0%400.0%0.00%0.0%
Q3 2020$1,0000.0%400.0%0.00%0.0%
Q2 2020$1,0000.0%400.0%0.00%0.0%
Q1 2020$1,0000.0%400.0%0.00%0.0%
Q4 2019$1,000400.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2019
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders